Amarin Corp Plcuk (AMRN) Cash from Investing Activities (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Cash from Investing Activities of -$8.3 million for Q1 2026, down 168.78% YoY from $12.1 million in Q1 2025, and down 136.01% sequentially from -$3.5 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Cash from Investing Activities across 16 years of filings, most recently posting -$8.3 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 168.78% year-over-year to -$8.3 million; the TTM figure through Mar 2026 stood at -$11.5 million (up 81.59% YoY), while the FY2025 annual figure was $8.8 million, up 119.2% from the prior year.
  • Cash from Investing Activities retreated to -$8.3 million in Q1 2026, from -$3.5 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for AMRN reached as high as $99.0 million in Q1 2022 and fell as low as -$71.0 million in Q4 2023.
  • The 5-year median for Cash from Investing Activities is $4.7 million (2024), against an average of $6.1 million.
  • The widest YoY moves for Cash from Investing Activities: up 246.45% in 2024, down 283.8% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$27.8 million in 2022, then sank by 155.22% to -$71.0 million in 2023, then jumped by 67.83% to -$22.8 million in 2024, then soared by 84.61% to -$3.5 million in 2025, then slumped by 136.01% to -$8.3 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$8.3 million, -$3.5 million, and -$12.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -3.92 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -1.04 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -574.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -1.79 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -10.21 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -716.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.77 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 785.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -8.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.30 Mn
Mar 31, 2026 -8.30 Mn
Dec 31, 2025 -3.52 Mn
Dec 31, 2025 -3.52 Mn
Sep 30, 2025 -12.13 Mn
Sep 30, 2025 -12.13 Mn
Jun 30, 2025 12.41 Mn
Jun 30, 2025 12.41 Mn
Mar 31, 2025 12.06 Mn
Mar 31, 2025 12.06 Mn
Dec 31, 2024 -22.84 Mn
Dec 31, 2024 -22.84 Mn
Sep 30, 2024 -56.55 Mn
Sep 30, 2024 -56.55 Mn
Jun 30, 2024 4.70 Mn
Jun 30, 2024 4.70 Mn
Mar 31, 2024 28.72 Mn
Mar 31, 2024 28.72 Mn
Dec 31, 2023 -71.00 Mn
Dec 31, 2023 -71.00 Mn